Apple Inc. vs. HEPION PHARMS INC
Apple Inc. (AAPL) comes out ahead, leading on 3 of 3 compared factors.
Size & Scale
| AAPL | HEPA | |
|---|---|---|
| Market Cap | $4.92 trillion | — |
| Revenue (TTM) | $466.82 billion | — |
| Net Income (TTM) | $128.93 billion | $-3,188,419 |
AAPL leads on 2 of 2 size & scale factors.
Valuation
| AAPL | HEPA | |
|---|---|---|
| P/E Ratio | 38.55 | — |
| Price / Book | 45.74 | — |
| Price / Sales | 10.54 | — |
AAPL and HEPA split the valuation factors evenly.
Profitability
| AAPL | HEPA | |
|---|---|---|
| Net Margin | 27.62% | — |
| Return on Equity | 119.91% | -249.38% |
AAPL leads on 1 of 1 profitability factors.
Dividend
| AAPL | HEPA | |
|---|---|---|
| Dividend Yield | 0.32% | — |
| Payout Ratio | 12.39 | — |
AAPL and HEPA split the dividend factors evenly.
Risk & Sentiment
| AAPL | HEPA | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and HEPA split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, HEPA overview, HEPA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.